Redwood Scientific Technologies, Inc. develops and markets homeopathic products which feature oral strip delivery technology. The company is headquartered in Albany, New York. The company went IPO on 2008-03-12. RST utilizes Patent-pending, sublingual strip delivery technology that enhances bioavailability. The main product, Prolongz, is designed to treat premature ejaculation in men. Prolongz has been registered with the FDA #079526408, allowing Redwood to elevate ourselves from competitors. Redwoods Prolongz is on course to establish ourselves as the industry leader for the adult male sexual performance dysfunction market through our membership (subscription) model. The firm is aggressively expanding our customer population through heavy investments in national cable television commercials and infomercials which also drives consumer awareness and retail sales. Source: Crunchbase
Follow-Up Questions
What is Redwood Scientific Technologies Inc (RSCI)'s P/E Ratio?
The P/E ratio of Redwood Scientific Technologies Inc is N/A
What is the price performance of RSCI stock?
The current price of RSCI is 0, it has decreased 0% in the last trading day.
What are the primary business themes or industries for Redwood Scientific Technologies Inc?
Redwood Scientific Technologies Inc belongs to Consumer products industry and the sector is Consumer Staples
What is Redwood Scientific Technologies Inc market cap?
Redwood Scientific Technologies Inc's current market cap is $0
Is Redwood Scientific Technologies Inc a buy, sell, or hold?
According to wall street analysts, 0 analysts have made analyst ratings for Redwood Scientific Technologies Inc, including 0 strong buy, 0 buy, 0 hold, 0 sell, and 0 strong sell
